Contrast-enhanced US quantitatively detects changes of tumor perfusion in a murine breast cancer model during adriamycin chemotherapy

Background Currently used morphologic criteria have limitations in assessing tumor response to chemotherapy because of the relatively slow tumor shrinkage as measured by conventional morphologic imaging. Functional imaging techniques show promising results in early assessment of tumor response to tr...

Full description

Saved in:
Bibliographic Details
Published in:Acta radiologica (1987) 2013-10, Vol.54 (8), p.882-888
Main Authors: Wang, Jian-wei, Cao, Long-hui, Han, Feng, Zheng, Wei, Chen, Yao, Li, An-hua, Zhou, Jian-hua
Format: Article
Language:English
Subjects:
Animals
Antibiotics, Antineoplastic - therapeutic use
Breast Neoplasms - blood supply
Breast Neoplasms - diagnostic imaging
Breast Neoplasms - drug therapy
Contrast Media
Disease Models, Animal
Doxorubicin - therapeutic use
Female
Image Enhancement - methods
Image Processing, Computer-Assisted - methods
Mice
Mice, Nude
Perfusion Imaging - methods
Phospholipids
Sodium Chloride - administration & dosage
Sulfur Hexafluoride
Ultrasonography
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Currently used morphologic criteria have limitations in assessing tumor response to chemotherapy because of the relatively slow tumor shrinkage as measured by conventional morphologic imaging. Functional imaging techniques show promising results in early assessment of tumor response to treatment. Purpose To quantitatively detect changes in tumor perfusion during chemotherapy with contrast-enhanced ultrasound. Material and Methods Twenty-three MCF-7 breast cancer bearing nude mice treated by either adriamycin (n = 11) or sterile saline (n = 12) were imaged before and after treatment with an ultrasound scanner after bolus injection of SonoVue. Regions of interest within the tumor were analyzed offline to determine perfusion parameters including peak enhancement (PE), area under the curve of wash-in (WiAUC), rise time (RT), wash-in rate (WiR), wash-in perfusion index (WiPI), and quality of fit (QOF). Hematoxylin and eosin was used to assess tumor cell density and immunohistochemical analysis was performed for evaluation of microvascular density (MVD). Results Treatment with adriamycin significantly reduced tumor growth in comparison to the control group (P < 0.001). There was no significant difference in perfusion parameters before treatment. Treatment with adriamycin resulted in a significant decrease in PE, WiAUC, WiR, and WiPI in comparison with control group (P < 0.01). The tumor cell density estimated by pathology slice was significantly lower in treated tumors than in control tumors after treatment (P < 0.001). Immunohistochemistry showed significant decreases of MVD in treated tumors as compared with control tumors (P < 0.001) after treatment. Conclusion Quantitative contrast-enhanced ultrasound can detect the change of tumor perfusion after chemotherapy, which may enable early assess tumor response to chemotherapy.
ISSN:0284-1851
1600-0455
DOI:10.1177/0284185113488019